Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYPB - Cypress BioScience -- Ignore unavailable to you. Want to Upgrade?

To: muddphudd who wrote (415)	10/12/1998 5:14:00 PM
From: Meisterama	Read Replies (1) \| Respond to of 586

If all he knows about the company is from a reading of a single 10Q, then his opinion is not worth much. Fortunately, you and I and others have done enough additional real research to know that this is NOT a crap shoot. I agree that anyone investing in CYPB at this time is probably doing so based on expected approval and sales of one product, the Prosorba column for RA indications -- but I am confident this single product justifies expectations of a substantial increase in this company's value. News of a partner will FOLLOW formal approval, for obvious reasons.